Dr Sarah Bowden is an NIHR funded Academic Clinical Lecturer at Imperial College London and training as a surgical subspecialist in Gynaecological Oncology at Hammersmith Hospital.

Dr Bowden first came to Imperial College as an intercalated BSc student in 2010 to study Global Health. After completing her medical degree from Cardiff University she took an ACF post in Obstetrics and Gynaecology and was awarded an Imperial Health Charity pre-doctoral fellowship and Genesis Trust grant to work on HPV epigenetic signatures in cervical cancer, and completed a PGCert in Genomic Medicine. Under a Wellcome Trust 4i Clinical Scientist fellowship she completed her PhD in 2022 at Imperial College, exploring genetic and epigenetic signatures for early detection of cervical cancer, supervised by Prof Maria Kyrgiou, Dr James Flanagan (Departments of MDR/Surgery & Cancer) and Prof Marc Chadeau-Hyam (School of Public Health)

As an ACL she is currently co-supervising MSc and PhD students in follow-on work on from her doctorate, particularly in the translational applications of OMICS technologies for the early detection and personalised management of women with cervical and endometrial cancers. Her interest is in enhancing screening for gynaecological cancers with novel molecular approaches, as well as fertility-sparing approaches. This work includes collaborations with teams in UCLA and Institute Pasteur Dakar in Senegal.

Sarah also sits on the ESGO prevention committee, Royal Society of Medicine (RSM) O&G section council and the British Society of Colposcopy and Cervical Pathology (BSCCP) scientific committee.